North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Brexpiprazole Intermediate (CAS <strong>913614-18-3</strong>) is a key synthetic precursor for the antipsychotic drug Brexpiprazole. It features the molecular formula <strong>C20H22FN3O2</strong>. This compound is primarily manufactured via advanced heterocyclic coupling and reduction processes to ensure high purity suitable for pharmaceutical synthesis.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Serves as the critical building block for synthesizing active pharmaceutical ingredients (APIs).</li>
<li><strong>R&D Laboratories:</strong> Utilized in stability studies and formulation development for new psychiatric treatments.</li>
<li><strong>Quality Control:</strong> Applied as reference standards in analytical testing of final drug products.</li>
</ul>
<h3>Precautions</h3>
<p>Storage requires sealed containers at controlled temperatures below 25°C in dry environments. Personnel must utilize appropriate PPE including gloves and respirators to prevent inhalation or skin contact during handling.</p>